A minimally invasive treatment for early GI cancers

Lady Katherine Mejía-Pérez; Seiichiro Abe; Tyler Stevens; Mansour A Parsi; Sunguk N Jang; Ichiro Oda; John J Vargo; Yutaka Saito; Amit Bhatt

doi:10.3949/ccjm.84a.16063

A minimally invasive treatment for early GI cancers

Cleve Clin J Med. 2017 Sep;84(9):707-717. doi: 10.3949/ccjm.84a.16063.

Authors

Lady Katherine Mejía-Pérez¹, Seiichiro Abe², Tyler Stevens^{3

4}, Mansour A Parsi³, Sunguk N Jang³, Ichiro Oda², John J Vargo^{5

4}, Yutaka Saito², Amit Bhatt^{6

7}

Affiliations

¹ Department of Internal Medicine, Cleveland Clinic, Cleveland, OH, USA.
² Endoscopy Division, National Cancer Center Hospital, Tokyo, Japan.
³ Department of Gastroenterology and Hepatology, Digestive Disease Institute, Cleveland Clinic, Cleveland, OH, USA.
⁴ Associate Professor, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH, USA.
⁵ Chairman, Department of Gastroenterology and Hepatology, Digestive Disease Institute, Cleveland Clinic, Cleveland, OH, USA.
⁶ Department of Gastroenterology and Hepatology, Digestive Disease Institute, Cleveland, OH, USA. [email protected].
⁷ Clinical Assistant Professor, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH, USA.

PMID: 28885903
DOI: 10.3949/ccjm.84a.16063

Abstract

Endoscopic submucosal dissection (ESD) allows curative resection of early malignant gastrointestinal (GI) lesions, potentially avoiding open surgery. Unfortunately, awareness of this technique is low, and many patients undergo surgery without consideration of ESD. This article reviews the indications for ESD and its advantages and limitations, and guides internists in their approach to patients with early GI cancer.

Publication types

Review

MeSH terms

Dissection
Endoscopy
Gastrointestinal Neoplasms / pathology*
Gastrointestinal Neoplasms / surgery*
Humans
Patient Selection